Carregant...

The novel MAGL inhibitor MJN110 enhances responding to reward-predictive incentive cues by activation of CB1 receptors

CB1 receptor antagonists disrupt operant responding for food and drug reinforcers, and cue-induced reinstatement of cocaine and heroin seeking. Conversely, enhancing endocannabinoid signaling, particularly 2-arachidonyl glycerol (2-AG), by inhibition of monoacyl glycerol lipase (MAGL), may facilitat...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neuropharmacology
Autors principals: Feja, Malte, Leigh, Martin P.K., Baindur, Ajay N., McGraw, Justin J., Wakabayashi, Ken T., Cravatt, Benjamin F., Bass, Caroline E.
Format: Artigo
Idioma:Inglês
Publicat: 2019
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6983961/
https://ncbi.nlm.nih.gov/pubmed/31628934
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neuropharm.2019.107814
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!